Digital health company Epitel, focused on modernizing brain health solutions, has secured $26.0M in Series B funding. The investment will accelerate its efforts to improve seizure monitoring and detection, a critical need for patients and clinicians in neurological care.
The round saw participation from Catalyst Health Ventures and Genoa Ventures, who are backing Epitel's vision to bring more advanced and accessible technological tools to this vital area of brain health.

















